Partnering with TransCode

If you share our vision and passion for transforming cancer treatment, reach out. ​

• Immunotherapy - Checkpoint Inhibitors (targeting PDL1/PD-1); Pattern Recognition Receptors - targeting RIG-I gene for innate immunity
• Gene-Editing - proprietary delivery of ribonucleoproteins
• Radiotherapy - as therapies or diagnostics
• Cancer Vaccines - employing delivery of mRNA to tumors
• Diagnostics - assessing biomarkers as diagnostic aides to earlier detection, monitoring success of therapy during treatment and monitoring success post treatment
• Other targeted therapies - including peptide, protein, or small molecule-based approaches.

Email: [email protected]

Important Notice: Recruitment Fraud Alert
We are aware of recruitment scams in which fraudsters pose as representatives of TransCode Therapeutics to deceive job seekers. Please note the following to protect yourself:
    •    We NEVER ask for payment or personal financial information during the recruitment process.
    •    All legitimate communication from our team will come from an official @transcodetherapeutics.com email address
    •    Our hiring process always includes formal interviews—either virtual or in-person.
    •    If you receive a  job offer claiming to be from us, please do NOT respond. Report it to [email protected].  ​